tirzepatide 12.5 mg Mounjaro (Tirzepatide) Injection mg/0.5 mL Syringes Mounjaro 12.5mg KwikPen (0.6ml per

Common side effects during the adjustment period (typically the first 24 weeks): Mild nausea usually less intense than when first starting a GLP-1 medication Changes in appetite (some patients notice less appetite suppression early on at the starting 0.25 mg dose) Mild stomach discomfort, bloating, or constipation Injection site reactions Side effects that are less likely during the switch (compared to first-time GLP-1 use), but still possible: Significant vomiting less common given prior GLP-1 exposure, but possible Hypoglycemia particularly relevant for type 2 diabetes patients on insulin or sulfonylureas

However, semaglutide remains a highly effective, gold-standard treatment that has a longer track record of use in the UK for weight management

Semaglutide is not a muscle-building drug, so no, it will not help you build muscle

Stunkard, A

We also thank R